Table III.

CT antigen expression in patients with medullary carcinoma.

P	Gender	Age, years	Size, cm	Tumor stage	Positive lymph node	Metastasis	Stage grouping	Angiolymphatic invasion	Extra-thyroidal extension	Multi MAGE-A	CT7 (MAGE-C1)	GAGE	CTAG1B
1	F	40	3.0	T1N0M0	No	No	I	No	No	1+	1+	f	–
2	F	57	2.4	T1N1bM0	No	No	II	No	No	–	–	f	–
3	F	38	2.7	T1N1aM0	No	No	II	No	No	f	f	f	–
4	F	67	3.4	T3N0M0	Yes	Yes	III	No	No	1+	f	f	–
5	F	67	2.5	T1N0M0	No	No	II	No	No	–	f	f	–
6	F	40	3.0	T2N1bM1	No	No	I	Yes	Yes	f	–	f	–
7	M	56	1.5	T1N0M0	No	No	I	No	No	f	f	f	–
8	M	54	0.5	T2N1bM0	Yes	No	IV	No	No	f	f	f	–
9	M	53	1.2	T2N0M0	Yes	No	III	Yes	No	f	f	f	f
10	F	48	4.2	T1N0M0	No	No	III	No	No	f	f	f	–
11	F	42	1.0	T1N0M0	No	No	I	No	No	1+	–	f	–
12	M	65	3.0	T4bN0M1	Yes	Yes	IV	Yes	No	–	f	f	–
13	F	17	0.5	T1N0M0	No	No	I	No	No	–	–	–	–
14	F	50	2.0	T1N1bM0	Yes	No	IV	Yes	No	–	–	f	–
15	F	33	2.3	T1N0M0	No	No	II	No	No	–	–	–	–
16	F	60	1.7	T1N0M0	No	No	I	No	Yes	–	–	f	–
17	F	63	1.3	T2N1aM0	No	No	I	No	No	–	–	f	–
18	M	29	1.0	T2N1bM0	No	Yes	IV	Yes	Yes	1+	f	f	–
19	F	77	0.6	T2N1aM0	No	No	I	No	No	–	–	f	–
20	M	14	1.2	T2N0M0	Yes	No	IV	Yes	Yes	f	f	f	–
21	M	53	0.5	T1N0M0	No	No	I	No	No	–	–	f	–
22	M	35	0.6	T2N0M0	No	No	I	No	No	–	–	f	–
23	F	31	2.5	T1N0M0	Yes	No	III	Yes	No	f	–	f	–
24	F	25	2.5	T1N1bM0	Yes	No	IV	Yes	No	–	f	f	–
25	F	49	3.2	T1N1aM0	Yes	No	III	Yes	Yes	–	–	f	–
26	F	60	2.8	T3N0M0	No	No	II	No	No	–	f	f	–
27	M	55	1.4	T1N0M0	No	No	I	No	No	–	–	f	–
28	F	54	2.0	T2N1bM1	No	No	II	No	No	–	–	f	–

P, patient number; F, female; M, male; CT antigen, cancer/testis antigen; MAGE-A, melanoma-associated antigen A; MAGE-C1/CT7, melanoma-associated antigen C1; CTAG1B, cancer/testis antigen 1B; GAGE, G antigen; TNM, tumor-node-metastasis; f, focal.